Mustang Bio Inc
MBIO
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.39M
Close$
$0.35
38.3% downside
Current Fair Value
38.3% downsideOvervalued by 38.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.39 Million |
|---|---|
| Enterprise Value | $-10,764,898.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.39 |
| Beta | 2.05 |
| Outstanding Shares | 6,732,970 |
Return
| Return on Equity | -40.20% |
|---|---|
| Return on Assets | -19.43% |
| Return on Invested Capital | -42.47% |
Valuation & Multiples
| P/E Ratio | -1.29 |
|---|---|
| PEG | -3.17 |
| Price to Sales | - |
| Price to Book Ratio | 0.57 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 3.29 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
$-140.00
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 18, 2026
EPS Estimate
$-145.50
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 7.55%▼ 3.70% |
|---|---|
| Total Invested | $369,848▼ 31.75% |
| Investors Holding | 22▼ 2.00% |
ESG Score
No data